Publications

  1. Boland EG, Selvarajah D, Hunter M, Ezaydi Y, Tesfaye S, Ahmedzai SH, Snowden JA, Wilkinson ID. Central pain processing in chronic chemotherapy-induced peripheral neuropathy: a functional magnetic resonance imaging study. PLoS One. 2014 May 12; 9(5):e96474. doi: 10.1371/
  2. Selvarajah D, Cash T, Sankar A, Thomas L, Davies J, Cachia E, Gandhi R, Wilkinson ID, Wilkinson N, Emery CJ, Tesfaye S. The contributors of emotional distress in painful diabetic neuropathy. Diab Vasc Dis Res. 2014 May 12. [Epub ahead of print]
  3. Selvarajah D, Wilkinson IA, Maxwell M, Davies J, Sankar A, Boland E, Gandhi R, Tracey I, Tesfaye S. Cerebral Grey Matter Abnormalities in Subjects with Diabetic Neuropathy: A cross-sectional voxel-based morphometric study. Diabetes Care 2014; Jun;37(6):1681-8. doi: 10.2337/dc13-2610. Epub 2014 Mar 21.
  4. Selvarajah D, Cash T, Tesfaye S. The Contributors of Emotional Distress in Painful Diabetic Neuropathy. Diabetes and Vascular Disease Research 2014 (In Press)
  5. Leeds JS, Hopper AD, Hadjivassiliou M, Tesfaye S, Sanders DS. Potential coeliac disease in Type 1 diabetes mellitus: Does a positive antibody lead to increased complications? Nutr Metab Cardiovasc Dis. 2013 Oct 23. pii: S0939-4753(13)00237-8. doi: 10.1016/j.numecd.2013.09.005.
  6. Tesfaye S, Boulton AJ, Dickenson A. Mechanisms and Management of Diabetic Painful Distal Symmetrical Polyneuropathy: Bench to Bedside. Diabetes Care 2013; 36(9):2456-65.
  7. Voulgari C, Pagoni S, Tesfaye S, Tentolouris N. The Spatial QRS-T Angle: Implications in Clinical Practice. Curr Cardiol Rev. 2013; 9(3):197-210.
  8. Tesfaye S, Wilhelm S, Lledo A, Schacht A, Tölle T, Bouhassira D, Cruccu G, Skljarevski V, Freynhagen R. Duloxetine and pregabalin: High-dose monotherapy or their combination? The "COMBO-DN study" - a multinational, randomized, double-blind, parallel-group study in patients with diabetic peripheral neuropathic pain. Pain. 2013; 154(12):2616-25.
  9. Wilkinson ID, Selvarajah D, Greig M, Shillo P, Boland E, Gandhi R, Tesfaye S. Magnetic resonance imaging of the central nervous system in diabetic neuropathy. Curr Diab Rep. 2013;13(4):509-16.
  10. Kurien M, Leeds JS, Hopper AD, Wild G, Egner W, Tesfaye S, Hadjivassiliou M, Sanders DS. Serological testing for coeliac disease in Type 1 diabetes mellitus: is immunoglobulin A level measurement necessary? Diabet Med. 2013; 30(7):840-5.
  11. Malik RA, Tesfaye S, Ziegler D. Medical strategies to reduce amputation in patients with Type 2 diabetes. Diabet Med. 2013; 30(8):893-900.
  12. Putz Z, Németh N, Istenes I, Martos T, Gandhi RA, Körei AE, Hermányi Z,Szathmári M, Jermendy G, Tesfaye S, Tabák AG, Kempler P. Autonomic dysfunction and circadian blood pressure variations in people with impaired glucose tolerance. Diabet Med. 2013; 30(3):358-62.
  13. Bosi E, Bax G, Scionti L, Spallone V, Tesfaye S, Valensi P, Ziegler D; on behalf of the FREMS European Trial Study Group. Frequency-modulated electromagnetic neural stimulation (FREMS) as a treatment for symptomatic diabetic neuropathy: results from a double-blind, randomized, multicentre, long-term, placebo-controlled clinical trial. Diabetologia 2013; 56(3):467-75.
  14. Dyck PJ, Albers JW, Wolfe J, Bolton CF, Walsh N, Klein CJ, Zafft AJ, Russell JW, Thomas K, Davies JL, Carter RE, Melton LJ 3rd, Litchy WJ; Clinical vs. Neurophysiology Trial 3 Investigators. A trial of proficiency of nerve conduction: greater standardization still needed. Muscle Nerve. 2013; 48(3):369-74.
  15. Ziegler D, Tesfaye S, Kempler P. Comment on: Fraser et al. The Effects of Long-Term Oral Benfotiamine Supplementation on Peripheral Nerve Function and Inflammatory Markers in Patients With Type 1 Diabetes: A 24-Month, Double-Blind, Randomized, Placebo-Controlled Trial. Diabetes Care 2012; 35: 1095-1097. DiabetesCare. 2012; 35(11): e79.
  16. Dyck PJ, Overland CJ, Low PA, Litchy WJ, Davies JL, Dyck P, Carter RE, Melton LJ, Andersen H, Albers JW, Bolton CF, England JD, Klein CJ, Llewelyn G, Mauermann ML, Russell JW, Selvarajah D, Singer W, Smith AG, Tesfaye S, Vella A. "Unequivocally Abnormal" vs. "Usual" Signs and Symptoms for Proficient Diagnosis of Diabetic Polyneuropathy: Cl vs. N Phys Trial. Arch Neurol. 2012; 69(12):1609-14.
  17. Beran D, Capewell S, de Courten M, Gale E, Gill G, Husseini A, Keen H, Motala  A, O'Flaherty M, Ramachandran A, Swinburn B, Tesfaye S, Unwin N, Wild S, Yudkin JS. The International Diabetes Federation: losing its credibility by partnering with Nestlé? Lancet. 2012; 380(9844): 805.
  18. Papanas N, Boulton AJ, Malik RA, Manes C, Schnell O, Spallone V, Tentolouris N, Tesfaye S, Valensi P, Ziegler D, Kempler P. Neuropad: A simple new non-invasive sweat indicator test for the diagnosis of diabetic neuropathy. Diabet Med. 2012; 30(5):525-34.
  19. Barkai L, Gurieva I, Striban A, Tesfaye S, Czupryniac L, Mankovsky B, Spallone V, Veresiu IA, Schnell O, Kempler P. Microvascular complications in children and adolescents with T1 DM. Diabetes Stoffw Herz 2012; 21: 309-15.
  20. Schoenaker DA, Toeller M, Chaturvedi N, Fuller JH, Soedamah-Muthu SS; EURODIAB Prospective Complications Study Group. Dietary saturated fat and fibre and risk of cardiovascular disease and all-cause mortality among type 1 diabetic patients: the EURODIAB Prospective Complications Study. Diabetologia. 2012; 55(8):2132-41.
  21. Tesfaye S, Selvarajah D. Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy. Diabetes Metab Res Rev. 2012; 28 Suppl 1:8-14.
  22. Nin JW, Ferreira I, Schalkwijk CG, Prins MH, Chaturvedi N, Fuller JH, Stehouwer CD; EURODIAB Prospective Complications Study Group. Serum high-mobility group box-1 levels are positively associated with micro- and macroalbuminuria but not with cardiovascular disease in type 1diabetes: the EURODIAB Prospective Complications Study. Eur J Endocrinol. 2012; 166(2):325-32.
  23. Selvarajah D, Wilkinson ID, Gandhi R, Griffiths PD, Tesfaye S. Microvascular perfusion abnormalities of the Thalamus in painful but not painless diabetic polyneuropathy: a clue to the pathogenesis of pain in type 1 diabetes. Diabetes Care 2011; 34(3): 718-20.
  24. Leeds JS, Hopper AD, Hadjivassiliou M, Tesfaye S, Sanders DS.  High prevalence of microvascular complications in adults with type 1 diabetes and newly diagnosed celiac disease. Diabetes Care 2011; 34(10): 2158-63.
  25. Kempler P, Amarenco G, Freeman R, Frontoni S, Horowitz M, Stevens M, Low P, Pop-Busui R, Tahrani A, Tesfaye S, Várkonyi T, Ziegler D, Valensi P; on behalf of the Toronto Consensus Panel on Diabetic Neuropathy. Gastrointestinal autonomic neuropathy, erectile-, bladder- and sudomotor dysfunction in patients with diabetes mellitus: clinical impact, assessment, diagnosis, and management. Diabetes Metab Res Rev 2011; 27: 665–77.
  26. Spallone V, Ziegler D, Freeman R, Bernardi L, Frontoni S, Pop-Busui R, Stevens M, Kempler P, Hilsted J, Tesfaye S, Low P, Valensi P; on behalf of the Toronto Consensus Panel on Diabetic Neuropathy. Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management. Diabetes Metab Res Rev 2011; 27: 639–53.
  27. Boulton AJ, Valensi P, Tesfaye S. The Diabetic Neuropathies: Reports from the Diabetic Neuropathy Expert Panel Meeting on Neuropathy, Toronto. Diabetes Metab Res Rev 2011; 27: 665–77.
  28. Tesfaye S, Vileikyte L, Rayman G, Sindrup S, Perkins B, Baconja M, Vinik A Boulton A; on behalf of the Toronto Expert Panel on Diabetic Neuropathy Painful Diabetic Peripheral Neuropathy: Consensus Recommendations on Diagnosis, Assessment and Management. Diabetes Metab Res Rev 2011; 27: 629–38.
  29. Bernardi L, Spallone V, Stevens M, Hilsted J, Frontoni S, Pop-Busui R, Ziegler D, Kempler P, Freeman R, Low P, Tesfaye S, Valensi P; on behalf of the Toronto Consensus Panel on Diabetic Neuropathy.  Investigation methods for cardiac autonomic function in human research studies. Diabetes Metab Res Rev 2011; 27: 654–664.
  30. Malik R, Veves A, Tesfaye S, Smith G, Cameron N, Zochodne D, Lauria G; on behalf of the Toronto Consensus Panel on Diabetic Neuropathy. Small Fiber Neuropathy: Role in the diagnosis of Diabetic Sensorimotor Polyneuropathy.  Diabetes Metab Res Rev 2011; 27: 678–684.
  31.  Selvarajah D, Wilkinson ID, Davies J, Gandhi R, Tesfaye S.  Central nervous system involvement in diabetic neuropathy. Curr Diab Rep 2011; 11(4): 310-22.
  32. Gill GV, Tekle A, Reja A, Wile D, English PJ, Diver M, Williams AJ, Tesfaye S. Immunological and C-peptide studies of patients with diabetes in northern Ethiopia: existence of an unusual subgroup possibly related to malnutrition. Diabetologia 2011; 54(1): 51-7.
  33. Tesfaye S, Boulton AJ, Dyck PJ, Freeman R, Horowitz M, Kempler P, Lauria G, Malik RA, Spallone V, Vinik A, Bernardi L, Valensi P on behalf of The Toronto Diabetic Neuropathy Expert Group.  Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity and Treatments. Diabetes Care 2010; 33(10): 2285-93. Cited 266 times.
  34. Charles M, Soedamah-Muthu SS, Tesfaye S, Fuller JH, Arezzo JC, Chaturvedi N, Witte DR; EURODIAB Prospective Complications Study Investigators. Low peripheral nerve conduction velocities and amplitudes are strongly related to diabetic microvascular complications in type 1 diabetes: the EURODIAB Prospective Complications Study. Diabetes Care 2010; 33(12): 2648-53.
  35. Tesfaye S, Chadwick P, Downie P, Hall G, Holt C, Mayor V, Stang D.  Diabetic peripheral neuropathic pain: The primary care perspective. Diabetes & Primary Care 2010; 12(Suppl 1): 2-8
  36. Narendran P, Creely SJ, Syed A, Tesfaye S, Winer J, Singh BM. Aggressive and devastating neuropathy: the consequence of untreated slow-onset type 1 diabetes. QJM. 2011; 104(6): 523-6.
  37. Dyck PJ, Overland CJ, Low PA, Litchy WJ, Davies JL, Dyck PJ, O'Brien PC; Cl vs. NPhys Trial Investigators, Albers JW, Andersen H, Bolton CF, England JD, Klein CJ, Llewelyn JG, Mauermann ML, Russell JW, Singer W, Smith AG, Tesfaye S, Vella A.  Signs and symptoms versus nerve conduction studies to diagnose diabetic sensorimotor polyneuropathy:  Cl vs. NPhys trial. Muscle Nerve 2010; 42(2): 157-64.
  38. Gandhi RA, Marques JL, Selvarajah D, Emery CJ, Tesfaye S. Painful diabetic neuropathy is associated with greater autonomic dysfunction than painless diabetic neuropathy. Diabetes Care. 2010; 33(7):1585-90
  39. Tesfaye S. Recent advances in the management of distal symmetrical polyneuropathy. J Diab Invest 2011; 2 (1): 33-42.
  40. Tesfaye S. Neuropathy in diabetes. Medicine 2010; 38: 649-55
  41. Ferrari GL, Marques JL, Gandhi RA, Heller SR, Schneider FK, Tesfaye S, Gamba HR. Using dynamic pupillometry as a simple screening tool to detect autonomic neuropathy in patients with diabetes: a pilot study. Biomed Eng Online 2010; 17: 9-26.
  42. Song SH, Gray TA, Tesfaye S. Time to rethink aspirin in diabetes? BMJ. 2009 23; 339:b5588.
  43. Selvarajah D, Gandhi R, Emery CJ, Tesfaye S. Randomized placebo-controlled double-blind clinical trial of cannabis-based medicinal product (Sativex) in painful diabetic neuropathy: depression is a major confounding factor. Diabetes Care. 2010; 33(1): 128-30.
  44. Leed JS, Forman EM, Morley S, Scott AR, Tesfaye S, Sanders DS. Abnormal liver function tests in patients with Type 1 diabetes mellitus: prevalence, clinical correlations and underlying pathologies. Diabet Med. 2009; 26(12): 1235-41.
  45. Tesfaye S, Selvarajah D. The Eurodiab study: what has this taught us about diabetic peripheral neuropathy? Curr Diab Rep. 2009; 9(6): 432-4.
  46. Tesfaye S. Advances in the management of painful diabetic neuropathy. 2009; 3(2): 136-43
  47. Gill G, Mbanya JC, Ramaiya KL KL, Tesfaye S. A sub-Saharan perspective of diabetes. Diabetologia 2009; 52(1):8-16.
  48. Gill GV, Gebrekidan A, English PJ, Tesfaye S. Improving glycaemic control in African diabetic patients on insulin: a resource-free approach. Trop Doct. 2009; 39(1): 3-5.
  49. Tesfaye S, Selvarajah D. Recent advances in the pharmacological management of painful diabetic neuropathy. Br J Diab and Vasc Dis2009; 9: 283-7.Curr Opin Support Palliat Care.
  50. Elliott J, Tesfaye S, Chaturvedi N, Gandhi RA, Stevens LK, Emery C, Fuller JH; the EURODIAB Prospective Complications Study Group.  Large fibre dysfunction in diabetic peripheral neuropathy is predicted by cardiovascular risk factors. Diabetes Care. 2009; 32(10):1896-900.
  51. Istenes I, Keresztes K, Hermányi Z, Putz Z, Vargha P, Gandhi R, Tesfaye S, Kempler P. Non-invasive evaluation of neural impairment in subjects with impaired glucose tolerance. Diabetes Care 2009; 32(1): 181-3.
  52. Selvarajah D, Wilkinson ID, Emery CJ, Harris ND, Shaw PJ, Witte DR, Griffiths PD, Tesfaye S.  Thalamic neuronal dysfunction in type 1 patients with diabetic peripheral neuropathy. Diabetologia 2008; 51(11): 2088-92.
  53. Gill G, Gebrekidan A, English P, Wile D, Tesfaye S. Diabetic complications and glycaemic control in remote North Africa. QJM. 2008; 101(10): 793-8.
  54. Istenes I, Keresztes K, Hermányi Z, Putz Z, Vargha P, Gandhi R, Tesfaye S, Kempler P. Relationship between autonomic neuropathy and hypertension: are we underestimating the problem? Diabet Med 2008; 25(7): 863-66.
  55. Soedamah-Muthu SS, Chaturvedi N, Witte DR, Stevens LK, Porta M, Fuller JH; EURODIAB Prospective Complications Study Group. Relationship between risk factors and mortality in type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study (PCS). Diabetes Care. 2008; 31(7): 360-6.  
  56. Sindrup SH, Tesfaye S, Otto M, Bach FM. Systematic review on treatments for painful diabetic neuropathy skips important studies and accepts dubious findings in others leading to an invalid treatment algorithm.  BMJ 2007; 335: 87
  57. Rubino A, Rousculp MD, Davis K, Wang J, Bastyr EJ, Tesfaye S. Diagnosis of diabetic peripheral neuropathy among patients with type 1 and type 2 diabetes in France, Italy, Spain, and the United Kingdom. Prim Care Diabetes 2007; 1(3): 129-34.
  58. McDermott C, Gandhi R, Tesfaye S, Ackroyd R. Surgical treatment of obesity. Student BMJ 2007; 15: 411-12.
  59. Moustafa M, Bullock AJ, Creagh FM, Heller S, Jeffcoate W, Game F, Amery C, Tesfaye S, Ince Z, Haddow DB, MacNeil S. Randomized, controlled, single-blind study on use of autologous keratinocytes on a transfer dressing to treat non-healing diabetic ulcers. Regen Med. 2007; 2(6): 887-902.
  60. Ferrari GL, Marques JL, Gandhi RA, Emery CJ, Tesfaye S, Heller SR, Schneider FK, Gamba HR. An approach to the assessment of diabetic neuropathy based on dynamic pupillometry. Conf Proc IEEE Eng Med Biol Soc. 2007; 1:557-60.
  61. Tesfaye S, Tandan R, Bastyr EJ, Kles KA, Skljarevski V, Price KA. Factors that impact on symptomatic diabetic peripheral neuropathy in placebo-treated patients from a two 1-year clinical trials. Diabetes Care 2007; 30(10):2626-32.
  62. Quattrini C, Harris ND, Malik RA, Tesfaye S. Impaired skin microvascular reactivity in painful diabetic neuropathy. Diabetes Care 2007; 30: 655-9.
  63. Tesfaye S. Is epalrestat an effective treatment for diabetic peripheral neuropathy? (Commentary) Nature Clin Pract Endoc & Metab 2007; 3(2):84-5.
  64. Quattrini C, Tavakoli M, Jeziorska M, Kallinikos P, Tesfaye S, Finnigan J, Marshall A, Boulton AJ, Efron N, Malik RA. Surrogate markers of small fiber damage in human diabetic neuropathy. Diabetes. 2007; 56(8): 2148-54.
  65. Tesfaye S, Selvarajah D.  Morphine, Gabapentin and combination for neuropathic pain. New Engl J Med 2005; 352(25): 2650-1 (letter).
  66. Tesfaye S. Advances in the management of painful diabetic neuropathy. Clin Med 2007; 7: 4-5.
  67. Selvarajah D, Tesfaye S. Central nervous system involvement in diabetes mellitus. Curr Diab Rep. 2006; 6(6):431-8.
  68. Jensen TS, Backonja MM, Hernandez Jimenez S, Tesfaye S, Valensi P, Ziegler D. New perspectives on the management of diabetic peripheral neuropathic pain. Diab Vasc Dis Res. 2006; 3: 108-19.
  69. Tesfaye S. Neuropathy in Diabetes. Medicine 2006; 34(3): 91-94.
  70. Selvarajah D, Wilkinson ID, Emery CJ, Harris ND, Shaw PJ, Witte DR, Griffiths PD, Tesfaye S.  Early involvement of the spinal cord in diabetic peripheral neuropathy. Diabetes Care 2006; 29(12):2664-9.
  71. Malik R, Veves A, Tesfaye S. Ameliorating human diabetic neuropathy: lessons from hematopoietic mononuclear cells. Exp Neurol 2006: 201(1): 7-14.
  72. Tesfaye S, Kempler P. Painful diabetic neuropathy. Diabetologia 2005; 48(5): 805-7.
  73. Vinik AI, Bril V, Kempler P, Litchy WJ, Tesfaye S et al.  Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C beta-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial. Clin Therapeutics 2005; 27(8): 1164-80.
  74. Tesfaye S, Chaturvedi N, Eaton SE, Ward JD, Manes C, Ionescu‑Tirgoviste C, Witte D,  Fuller JH.  Vascular risk factors and diabetic neuropathy. New Engl J Med 2005; 352(4): 341-350. Cited 611 times
  75. Malik RA, Tesfaye S, Newrick PG et al.  Sural nerve pathology in diabetic patients with minimal but progressive neuropathy. Diabetologia 2005; 48: 578-85.
  76. Witte DR, Tesfaye S, Chaturvedi N at al. the EURODIAB Prospective Complications Study Group. Risk factors for cardiac autonomic neuropathy in Type 1 diabetes.  Diabetologia 2005; 48: 164-171.
  77. Tesfaye S, Witte D, Fuller JH.  Vascular risk factors and diabetic neuropathy. New Engl J Med 2005; 352(18): 1925-1927 (letter)
  78. Moustafa M, Simpson C, Glover M, Dawson RA, Tesfaye S, Creagh FM, Haddow D, Short R, Heller S, MacNeil. A new autologous keratinocyte dressing treatment for non-healing diabetic neuropathic foot ulcers. Diabetic Medicine 2004; 21:786-9.
  79. Rogers LC, Alam U, Tesfaye S, Malik RA. Treatment of painful diabetic neuropathy: a review of the most efficacious treatments. Practical Diabetes International 2004; 21: 301-6.
  80. Tesfaye S. Diabetic neuropathy: achieving best practice. Br J Vasc Dis 2003; 3: 112-7.
  81. Gebrekidan A, Gill G, Wile D, Gill A, Tesfaye S. An accurate and portable system for glycated haemoglobin measurement in the tropics. Tropical Doctor 2004; 34, 95-6.
  82. Tesfaye S. Epidemiology and etiology of diabetic peripheral neuropathies. Jones Hopkins Advanced Studies in Medicine 2004; 4: S1014-S1020.
  83. Powell L, Tesfaye S, Ackroyd R, Sanders DS. Surgical presentation of ischaemic hepatitis. Postgrad Med J 2003; 79: 350-1.
  84. Merza Z, Tesfaye S. The risk factors for diabetic foot ulceration. The Foot 2003; 13: 125-9.
  85. Quattrini C, Tesfaye S. Understanding the impact of painful diabetic neuropathy. Diabetes Metab Res Rev 2003; Suppl 1: S1-S8.
  86. Eaton SE, Harris ND, Ibrahim S, Patel K, Selmi F, Radatz M, Ward JD, Tesfaye S.  Differences in sural nerve haemodynamics in painful and painless neuropathy. Diabetologia 2003; 934-9.
  87. Kempler P, Tesfaye S, Chaturvedi N, Stevens LK, Webb DJ, Eaton S, Kerenyi Z, Tamas G, Ward JD, Fuller JH. The prevalence of autonomic neuropathy and potential risk factors: the Eurodiab IDDM Complications Study. Diabetic medicine2002; 19: 900-909.
  88. Rajbhandari SM, Jenkins R, Davies C, Tesfaye S. Charcot neuroarthropathy in diabetes mellitus. Diabetologia 2002; 1085-96.
  89. Elliott J, Hallsworth J, Sutton MR, Tesfaye S.  Multidiciplinary Diabetic Assessment Tool: a quick and comprehensive system for the diabetic foot clinic. Practical Diabetes International 2002; 19: 139.
  90. Scott LA, Tesfaye S. Measurement of somatic neuropathy for clinical practice and clinical trials. Current Diabetes Reports 2001; 1: 208-15.
  91. Tesfaye S. Clinical Scenario: Diabetic Neuropathy. Diabetic Med. 2001; 18 (Suppl. 3): 7-11.
  92. Cameron NE, Eaton SE, Cotter MA, Tesfaye S. Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy. Diabetologia 2001; 44: 1973-88. Cited 466 times
  93. Kempler P, Tesfaye S, Chaturvedi N, Stevens LK, Webb DJ, Eaton S, Kerenyi Z, Tamas G, Ward JD, Fuller JH. Blood pressure response to standing in the diagnosis of autonomic neuropathy: the Eurodiab IDDM Complications Study. Arch Physiol Biochem 2001; 109: 215-22.
  94. Eaton SE, Harris ND, Rajbhandari SM, Greenwood P, Wilkinson ID, Ward JD, Griffiths PD, Tesfaye S.  Spinal-cord involvement in diabetic neuropathy. Lancet 2001; 358: 35-6.
  95. Rajbhandari SM, Sutton M, Davies C, Tesfaye S, Ward JD. “Sausage toe”: a reliable sign of underlying osteomyelitis. Diabetic Med 2000; 17: 74-7.
  96. Rajbhandari SM, Harris ND, Tesfaye S, Ward JD.  Early identification of diabetic foot ulcers that may require intervention: by microlight spectrophotometer. Diabetes Care 1999; 22: 1292-5.
  97. Eaton SE, Tesfaye S. Clinical manifestations and measurement of somatic neuropathy. Diabetes Rev. 1999; 7: 312-25.
  98. Rajbhandari SM, Nikookam K, Tesfaye S. Assessment of painful neuropathy. Diabetic Foot 1999; 2(2 Suppl): 56-60.
  99. Gadour M, Rajbhandari SM, Tesfaye S. Cervical spine infection presenting as angina.  Hospital Medicine 1999; 60: 217-18.
  100. Habtu E, Gill G, Tesfaye S.   Is diabetes in Northern Ethiopia malnutrition related? Ethiopian Medical Journal 1999; 37: 263-67. 
  101. Rajbhandari SM, Sutton M, Lockett C, Eaton S, Godour M, Harris ND, Tesfaye S, Ward JD. Digital imaging: an accurate method of measurement of foot ulcers. Diabetic Med. 1999; 16: 339-42.
  102. Tesfaye S, Achari V, Yang YT, Harding S, Bowden A, Vora JV.  Pregnant, vomiting and going blind. Lancet1998; 352: 1594.
  103. Tesfaye S, Gill G. Small vessel disease: a cause of foot ulceration in the neuropathic foot?  Practical Diabetes1997; 14: 78-9.
  104. Gill GV, Benbow S, Tesfaye S, Kadzmarcyk E. Painless fracture in the neuropathic foot. Post Graduate Medical Journal1997; 73: 241-2.
  105. Leese G, Tesfaye S, Dengler-Harles M, Laws F, Clarke DI, Gill GV, MacFarlane IA. Eye screening for diabetic patients using hospital optometrists.  Journal of the Royal College of Physicians1997; 31: 65-9.
  106. Tesfaye S, Watt J, Benbow SJ, Pang KA, Miles J, MacFarlane IA.  Electrical spinal cord stimulation for painful diabetic peripheral neuropathy. Lancet1996; 348: 1696-1701. Cited 214 times.
  107. Tesfaye S, Stevens L, Stephenson J, Fuller J, Platter ME, Ionescu-Tirgoviste C, Ward JD on behalf of the EURODIAB IDDM Study Group. The prevalence of diabetic neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study.  Diabetologia1996; 39: 1377-84.
  108. Thomas PK, Beamish NG, Small JR, King RH, Tesfaye S, Ward JD, Tsigos C, Young RJ. Boulton AJM. Paranodal structure in diabetic sensory polyneuropathy.  Acta Neuropathologica (Berl)1996: 92: 614-20.
  109. Gill GV, Lishman M, Kaczmarcyk E, Tesfaye S. Targeted screening for diabetes - the Liverpool Community Chiropody Diabetes screening Project. Quarterly Journal of Medicine 1996; 89: 229-32.
  110. Tesfaye S, Malik R, Harris N, Jakubowski, Mody C, Rennie IG, Ward JD. Arteriovenous shunting and proliferating new vessels in acute painful neuropathy of rapid glycaemic control (insulin neuritis).  Diabetologia1996; 39: 329-35.
  111. Bradley JL, Thomas PK, King RHM, Muddle JR, Ward JD, Tesfaye S, Boulton AJM, Tsigos C, Young RJ. Myelinated nerve fibre regeneration in diabetic sensory polyneuropathy: correlation with type of diabetes. Acta Neuropathologica1995: 90: 403-10.
  112. Tesfaye S, Malik R, Ward JD. Vascular factors in diabetic neuropathy-comment. Diabetologia 1995; 38: 837.
  113. Tesfaye S. Pathogenesis and treatment of diabetic polyneuropathy. International Diabetes Digest 1995; 6: 56-58.
  114. Reja A, Tesfaye S, Harris N, Ward JD.  Is ACE inhibition with lisinopril helpful in diabetic neuropathy?  Diabetic Medicine 1995; 12: 307-9.
  115. Tesfaye S, Ward JD. Endothelial dysfunction and diabetic angiopathy. Diabetologia 1994; 37: 1167-68.
  116. Tesfaye S. Microvascular and acute complications in IDDM patients: the EURODIAB IDDM Complications Multicentre Study.  Diabetologia 1994; 37: 278-85.
  117. Malik RA, Tesfaye S, Thompson SD, Veves A, Ward JD, Boulton AJM.  Transperineurial capillary abnormalities in the sural nerve of patients with diabetic neuropathy.  Microvas Research1994; 48: 236-245.
  118. Tesfaye S, Malik R, Ward JD. Vascular factors in diabetic neuropathy. Diabetologia1994; 37: 847-54. Cited 227 times.
  119. Tesfaye S. Microvascular factors in diabetic neuropathy. Current Med Literature1993; 10: 67-73.
  120. Tesfaye S. Diabetic Neuropathy: Current treatment and potential therapeutic approaches. (Round Table on Diabetic Neuropathy, Dusseldorf September 1994) Diabetes Nutrition and Metabolism1994; 7: 369-79.
  121. Malik RA, Tesfaye S, Thompson SD, Veves A, Boulton AJM, Ward JD.  Endoneurial localisation of microvascular damage in human diabetic neuropathy.  Diabetologia1993; 36: 454-9.
  122. Tesfaye S, Harris N, Jakubowski J, Mody C, Wilson RM, Rennie IG, Ward JD.  Impaired blood flow and arterio-venous shunting in human diabetic neuropathy: a novel technique of nerve photography and fluorescein angiography.  Diabetologia1993; 36: 1266-74. Cited 136 times.
  123. Tebbs SE, Lumbuwe CM, Tesfaye S, Gonzalez AM, Wilson RM. The influence of aldose reductase on oxidative burst in diabetic neutrophils. Diabetes Research and Clinical Practice1992; 15: 121-30.
  124. Tesfaye S, Ward JD. The role of vascular abnormalities in the pathogenesis of diabetic neuropathy.  Saudi Arabian Medical Journal 1992; 13(5): 387-92.
  125. Tesfaye S, Harris N, Wilson RM, Ward JD. Exercise induced conduction velocity increment: a marker of impaired blood flow in diabetic neuropathy. Diabetologia1992; 35: 155-9.
  126. Tesfaye S, Cullen DR, Woolley PD, Wilson RM. Diabetic ketoacidosis precipitated by genital herpes infection. Diabetes Research and Clinical Practice1991; 13: 83-4.

Book
Diabetic Neuropathy.  Tesfaye S, Boulton AJ (eds), Oxford University Press, Oxford 2009.

Book chapters in print:
  1. Schaper N and Tesfaye S. The diagnosis and clinical impact of diabetic distal symmetrical polyneuropathy (2014 In Press)
  2. Tesfaye S. Impact of painful diabetic neuropathy on patients.  In Painful Diabetic Neuropathy. Lawson E, Baconja M (Eds). Springer 2013 (In Press)
  3. Tesfaye S. Neuropathic pain in diabetes: diagnosis and management. In Pain and comorbidities: understanding and managing the complex patient. Giamberardino MA, Jensen TS (Eds), IASP, 2012 pp197-218
  4. Tesfaye S. Diabetic neuropathy. In Oxford Textbook of Endocrinology. Wass JAH (ed). Oxford University Press, Oxford, 2011, pp 1946-1954
  5. Tesfaye S. Neuropathies: what is new? In: Hot Topics In Diabetes. JP Vora (ed., 4th edn).  Synergy, Richmond, Surrey, 2011.
  6. Selvarajah, Wilkinson, Gandhi, Tesfaye S.  CNS involvement in Diabetic Neuropathy. In Diabetes and the Brain. Biessels GJ, Luchsinger JA (Eds.) Humana Press 2009 NY pp365-383
  7. Tesfaye S. Management of Autonomic Neuropathies. In: Hot Topics In Diabetes. JP Vora (ed., 3nd edn).  Synergy, Richmond, Surrey, 2009.
  8. Selvarajah S, Wilkinson IA, Gandhi R, Tesfaye S. Central nervous system involvement in diabetic neuropathy. In: Diabetes and the brain. Biessels GJ, Luchsinger JA. (eds) Humana Press 2009, pp 365-83.
  9. Tesfaye S. Diabetic Neuropathy. In: Diabetes in old age. D Sinclair (ed., 3rd edn).  Wiley-Blackwell, John Wiley and Sons, Chichester, West Sussex, 2010, pp137-46.
  10. Tesfaye S. Advances in the management of painful diabetic peripheral neuropathy. In: Hot Topics In Diabetes. JP Vora (ed., 2nd edn).  Synergy, Richmond, Surrey, 2009, pp 61-73.
  11. Tesfaye S. Advances in the management of painful diabetic neuropathy. In: Hot Topics in Diabetes. JP Vora (ed). Synergy, Richmond, Surrey,  2008, pp 41-7
  12. Tesfaye S. Clinical features of Diabetic Polyneuropathy. In: Diabetic Neuropathy Clinical Management, 2nd Edition. Veves A, Malik RA (eds), Humana Press Inc, Totowa, NJ, 2007, pp 243-58.
  13. Tesfaye S. Diabetic Polyneuropathy.  In: The Diabetic Foot: medical and Surgical Treatment. Diabetes and Cardiovascular Disease. Veves A, Giurini JM, LoGerfo FW (eds), Humana Press Inc, Totowa, NJ, 2006, pp 105-30.
  14. Tesfaye S. Diabetic Neuropathy. In: The foot in Diabetes, Boulton AJM, Cavanagh P, Rayman G (eds), 4th edition, John Wiley, 2006 pp 30-40.
  15. Eaton SE, Tesfaye S. Insulin, hypoglycaemia and peripheral neuropathy. In textbook of Diabetic Neuropathy. Gries FA, Dyck PJ, Low PA, Tomilson DR, Ziegler D (eds), Thieme medical publishers, 2003, pp 308-12.
  16. Cotter MA, Veves A, Tesfaye S, Cameron NE. Nerve blood flow. In textbook of Diabetic Neuropathy. Gries FA, Dyck PJ, Low PA, Tomilson D, Ziegler D (eds), Thieme medical publishers, 2003, pp 115-22.
  17. Tesfaye S. Diabetic neuropathy. In Oxford Textbook of Endocrinology. Wass JAH, Shallet SM (eds). Oxford University Press, Oxford, 2002, pp 1789-98.
  18.  Tesfaye S. Diabetic Polyneuropathy.  In: The Diabetic Foot: medical and Surgical Treatment. Diabetes and Cardiovascular Disease. Veves A, Giurini JM, LoGerfo FW (eds), Humana Press Inc, Totowa, NJ, 2002, pp 75-98.
  19. Malik RA, Tesfaye S, Ward JD. Vascular changes and Diabetic Neuropathy. In: Diabetes and Cardiovascular Disease. Johnstone MT, Veves A (eds), Humana Press Inc, NJ, 2001, pp 411-30.
  20. Tesfaye S. Pathophysiology of pain in diabetic neuropathy and non-pharmacological treatments. In: Management of Diabetic Neuropathy. Veves A (ed), Humana Press Inc, Totowa, NJ, 1998, pp 133-46.
  21. Tesfaye S, JD Ward. Clinical features of diabetic neuropathy. In: Management of Diabetic Neuropathy. Veves A (ed), 1998, pp 49-60.
  22. Ward JD, Tesfaye S. Pathogenesis of diabetic neuropathy. In: Textbook of diabetes. Pickup J, Williams G (ed), 1997, Vol .2, PP 49.1-49.19.
  23. Tesfaye S, Price D. Current treatment for diabetic neuropathy and potential therapeutic approaches. In: Diabetic neuropathy. Boulton AJ (ed), 1996, pp 159-81.
  24. Malik RA, Tesfaye S, Veves A, Sharma AK, Ward JD, Boulton AJM. The progression of microangiopathy with neuropathic severity. In: Diabetic neuropathy: new concepts & insights. Hotta N, Greene DA, Ward JD, Sima AAF, Boulton AJ (eds) Elsevier, Amsterdam, 1995, pp 131-35.

 Ambition:
1.  To provide the UK’s best service for diabetic patients with peripheral neuropathy.
2.  To pursue international-level research into the pathogenesis & treatment of diabetic neuropathy.
3.  To train undergraduate and postgraduate students in diabetes to the highest international standard.

Solomon Tesfaye

Honorary Professor

 

  • : +44 (0114) 250 7696
    Fax: +44 (0) 7775562849
  • DEPARTMENTDiabetic Medicine
    University of Sheffield

  • COUNTRYUK